About: Clinical Efficacy and Safety of Nivolumab: Results of a Multicenter, Open-label, Single-arm, Japanese Phase II study in Malignant Pleural Mesothelioma (MERIT)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Clinical Efficacy and Safety of Nivolumab: Results of a Multicenter, Open-label, Single-arm, Japanese Phase II study in Malignant Pleural Mesothelioma (MERIT) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 04 June 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu en xunu de 2019 (ast) scientific article published on 04 June 2019 (en) наукова стаття, опублікована 4 червня 2019 (uk)
publication date	wds:Q92523777-DE11ABDD-B5E5-47F2-A9B3-D5ED13ECF7B9
publication date	2019-06-04 00:00:00Z (xsd:dateTime)
author name string	wds:Q92523777-0E407DDB-419E-478A-B74E-AA99D9588059 wds:Q92523777-14CEBEE1-A563-43C9-B6C7-DACAF34DE426 wds:Q92523777-389921AB-12B6-4A5A-BEE0-93CBDBC70934 wds:Q92523777-3BACBAA8-164E-4139-A0AF-BFDC50D9E647 wds:Q92523777-61CA75DE-DA40-4CEC-B996-4629224A4A00 wds:Q92523777-6662B610-4311-43B1-8CE1-571FF7E9FEFC wds:Q92523777-696758D5-0608-48CB-941B-0E70DAF087D6 wds:Q92523777-751B804C-C137-4861-BC92-45CE16EAB137 wds:Q92523777-7D981092-D719-44DA-A710-ECCAFE5F5F13 wds:Q92523777-D3E3A560-7602-4AFD-93D9-E5A16B261CC1 wds:Q92523777-D54F428F-61BC-4DF9-834E-38D869A5071A wds:Q92523777-DAE4C009-0870-4013-9627-5E8029113687
author name string	Toshiaki Takahashi Toyoaki Hida Yuichiro Ohe Morihito Okada Keisuke Aoe Fumio Imamura Yoshinobu Namba Terufumi Kato Mitsuhiro Takenoyama Satoshi Oizumi Jun Hirano Kuninobu Kanai
rdfs:label	Clinical Efficacy and Safety of Nivolumab: Results of a Multicenter, Open-label, Single-arm, Japanese Phase II study in Malignant Pleural Mesothelioma (MERIT) (en) Clinical Efficacy and Safety of Nivolumab: Results of a Multicenter, Open-label, Single-arm, Japanese Phase II study in Malignant Pleural Mesothelioma (MERIT) (nl)
skos:prefLabel	Clinical Efficacy and Safety of Nivolumab: Results of a Multicenter, Open-label, Single-arm, Japanese Phase II study in Malignant Pleural Mesothelioma (MERIT) (en) Clinical Efficacy and Safety of Nivolumab: Results of a Multicenter, Open-label, Single-arm, Japanese Phase II study in Malignant Pleural Mesothelioma (MERIT) (nl)
name	Clinical Efficacy and Safety of Nivolumab: Results of a Multicenter, Open-label, Single-arm, Japanese Phase II study in Malignant Pleural Mesothelioma (MERIT) (en) Clinical Efficacy and Safety of Nivolumab: Results of a Multicenter, Open-label, Single-arm, Japanese Phase II study in Malignant Pleural Mesothelioma (MERIT) (nl)
author	wds:Q92523777-034EEDD6-05F6-4A99-9B73-B8EEF8884808 wds:Q92523777-34998596-734A-4A17-8C92-E4F70DD8B55E wds:Q92523777-B01DB1C7-8A8A-47E3-994B-03F46C615D09 wds:Q92523777-D9453498-5C9A-42EA-AEFC-93E5873C225D wds:Q92523777-DA7B36A4-7432-4E39-87B9-292AF1008A85
author	Nobukazu Fujimoto Kazuhiko Nakagawa Takashi Kijima Yuichiro Takeda Hiroshi Tanaka
title	wds:Q92523777-E74EE63A-FEEF-4E5F-B2C5-6FE8F8F66E5A
title	Clinical Efficacy and Safety of Nivolumab: Results of a Multicenter, Open-label, Single-arm, Japanese Phase II study in Malignant Pleural Mesothelioma (MERIT) (en)
page(s)	wds:Q92523777-A09B1B94-726B-4829-9853-2A89F0F89C8F
page(s)	5485-5492
instance of	wds:Q92523777-EC51A836-9FC1-4F71-93AF-C03E499158AC
instance of	scholarly article
main subject	wds:Q92523777-407053F5-9828-40E2-82A7-5E6E0201A967
main subject	malignant pleural mesothelioma
PubMed ID	wds:Q92523777-E916C023-FD2B-4BB1-A7DE-EF529DB0C495
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31164373
PubMed ID	31164373
published in	wds:Q92523777-D9337D15-9AB7-459E-AE72-9251B77AAC48
published in	Clinical Cancer Research
issue	wds:Q92523777-761A472E-E3B0-46F0-80CC-9EE70CCAB5A5
volume	wds:Q92523777-43AF36C2-E4BC-49C5-A47A-BCACA088CC92
issue	18
volume	25
DOI	wds:Q92523777-79CAE780-00BB-4094-B30A-FE1CE8D0EE26
DOI	http://dx.doi.org/10.1158/1078-0432.CCR-19-0103
DOI	10.1158/1078-0432.CCR-19-0103
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q92523777
is cites work of	Chemotherapy options versus "novel" therapies: how should we treat patients with malignant pleural mesothelioma Nivolumab resulting in persistently elevated troponin levels despite clinical remission of myocarditis and myositis in a patient with malignant pleural mesothelioma: case report Current evidence and future perspectives of immune-checkpoint inhibitors in unresectable malignant pleural mesothelioma Nivo-lution in Mesothelioma Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading? Nivolumab-induced immune thrombocytopenia in a patient with malignant pleural mesothelioma Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future Immunotherapy in Malignant Pleural Mesothelioma Tumour Treating Fields for mesothelioma: controversy versus opportunity Immunotherapy for mesothelioma: a critical review of current clinical trials and future perspectives Efficacy of PD-1/PD-L1 blockade monotherapy in clinical trials Immunotherapy trials in mesothelioma - promising results, but don't stop here Fully Human Antibodies for Malignant Pleural Mesothelioma Targeting Nivolumab in pre-treated malignant pleural mesothelioma: real-world data from the Dutch expanded access program Remarkable response to nivolumab in sarcomatoid malignant pleural mesothelioma with high PD-L1
is cites work of	wds:Q90612192-F4912EDB-E663-4FE8-BB7A-4BE2CE05A52B wds:Q95260361-530AB78E-0607-42D2-92F0-57ECDD98F648 wds:Q89881656-7C1D375F-876C-4C19-A01D-F25F286C8433 wds:Q90748160-B9C7B51A-9423-4E3E-AA0E-60CDB691DC34 wds:Q97885740-1DA1E9A2-0F78-477A-922C-F8D31B69DC0D wds:Q89622483-E2413461-DD5A-412B-ADFD-AD4E2EFD9146 wds:Q90179428-728189FF-9221-444F-A44E-2C1196EF9F95 wds:Q90808650-3CF83D61-DD79-430C-8C63-6D3D55600CC3 wds:Q90612209-4E1FDB3E-D78E-4433-AF9E-1BD4E40AFDA4 wds:Q91966584-3580B551-7964-4E5A-84FA-AE4284BAC034 wds:Q98164819-CC3C9E64-5FDB-4883-BA05-0BA4BFEFFDE3 wds:Q91812276-FC607612-7250-418B-B11C-B7BC53AC651E wds:Q99582736-C7553151-AACA-4FE8-98E8-13F4637764E7 wds:Q90782085-BA668CF6-C62D-4D6D-993F-B3A580EEE6E2 wds:Q90150433-B9AFBBA4-FC96-4897-B81B-4CAF1FB12463

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software